A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
Patients with lung cancer who have completed a course of treatment (or who are in-between
treatment) at the Royal Marsden Hospital would be eligible for inclusion in the study.
Participants will be randomised into 3 groups. Group 1 - this group will complete the QoL
questionnaire and will receive targeted therapies by a doctor (and other members of the
oncology team) during a clinic consultation. Group 2 - will complete the QoL questionnaire
however the questionnaire will not be seen by the doctor during a clinic consultation. Group
3 - the control group will not complete the QoL questionnaire before a clinic consultation.
All patients will complete a diary of all contact they have with health care professionals
during the study. The study will last for 6 weeks and at the end of the study all patients
will complete the QoL questionnaire.
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
To investigate whether the use of QOL questionnaires during the assessment and management of lung cancer patients results in improved quality of life
Dr M O'Brien
Royal Marsden NHS Foundation Trust
United Kingdom: Research Ethics Committee